150

Table 0.10 Marine derived drugs on the market Clinical Status Compound Name Cytarabine (Ara-C) Vidarabine (Ara-A) Ziconotide Eribulin Mesylate (E7389) FDA-Approved Omega-3-acid ethyl esters Trabectedin (ET-743) (EU Registered only) Brentuximab vedotin (SGN-35) Mollusk/ Adcetris® cyanobacterium Antibody drug conjugate (MM auristatin E) a) The marine pharmaceutical pipeline consists of natural products, analogs or derivatives of compounds b) On-going clinical/total trials as reported at http://www.clinicaltrials.gov/ in February 2013. Trademark Marine Organisma Cytosar-U® Vira-A® Prialt® Halaven® Lovaza® Yondelis® Sponge Sponge Cone snail Sponge Fish Tunicate Chemical Class Nucleoside Nucleoside Peptide Macrolide Omega-3 fatty acids Alkaloid 124 Study in support of Impact Assessment w

151 Publizr Home


You need flash player to view this online publication